Articles

In this salty dive into the USCF Gold Strategy Plus Income Fund (USG), we roast the technical indicators screaming 'buy' while questioning if gold's glitter is worth the grind in today's market mess. Factual takedown with zero BS advice.

A no-holds-barred, sarcasm-laced opinion on Presidio Property Trust's Series D Preferred Stock (SQFTP), roasting its latest news on earnings, dividends, and real estate moves while keeping it real with facts from recent updates.

In a market that's more bipolar than a teenager on TikTok, institutional investors are split on Replimune Group. Some are loading up like it's Black Friday at the casino, while others are hitting the eject button. We dive into this salty saga with a due diligence roast, keeping it real amid the biotech chaos.

In this salty opinion piece, we dive into NetApp's latest drama: executives cashing out millions while analysts shrug with a 'hold' rating. Is the hybrid cloud king stumbling, or just another day in the storage wars? Factual takedown ahead, no BS.

Montauk Renewables Inc. (MNTK) is getting hammered by softening biogas demand, skyrocketing costs, and a renewable sector that's about as stable as a Jenga tower in an earthquake. High interest rates and policy flip-flops are souring the vibe, leaving investors salty and reassessing their bets on this biogas play.

In this salty take, we roast Methanex's latest earnings flop and Scotiabank's grim FY2026 forecast revision, questioning if this methanol giant is leaking profits faster than a sieve. Factual due diligence with a side of sarcasm.

A no-holds-barred, salty take on Kwesst Micro Systems Inc (NASDAQ: KWE), where the share price is dropping faster than your ex's interest in commitment. We roast the recent 11% tumble and poke fun at the volatility, all while sticking to the facts from the latest data.

A salty dive into the iShares MSCI Intl Value Factor ETF (IVLU), roasting its recent price dip and the eternal struggle of value investing abroad, all while keeping it real with the facts.

A salty dive into Galaxy Digital's recent share price bounce, roasting the highs, lows, and pie-in-the-sky analyst targets while keeping it real on the crypto rollercoaster risks.

A salty take on the Fidelity Quality Factor ETF (FQAL), roasting its technical analysis like it's the blandest party guest at the market's rager. We dive into the charts, mock the middling signals, and question if 'quality' really means 'meh' in ETF land.

A salty take on Stanley Black & Decker's (SWK) business, roasting its recent stumbles while grudgingly nodding to its brand muscle and dividend grit. Factual due diligence with a side of sarcasm—no advice, just opinions on why it might make you question your toolbox.

NGL Energy Partners just pulled off a $950 million term loan refinance and preferred unit buyback, aiming to tidy up its messy balance sheet. But is this a genius move or just more debt-dodging drama? We dive in with a salty, factual take on the risks, rewards, and why investors might want to keep their salt shaker handy.

A salty take on the Innovator U.S. Equity 5 to 15 Buffer ETF - Quarterly (EALT), roasting its buffered strategy, capped upside, and why it might just be another fancy way to underperform SPY while pretending to protect your portfolio.

In this salty take, we roast Caledonia Mining's latest move to hawk $100 million in convertible notes, questioning if funding a Zimbabwe project is genius or just another mining pipe dream. Factual digs on the risks, the rewards, and why this smells like classic dilution desperation.

In this no-holds-barred opinion piece, we roast Rio Tinto's latest fatal safety blunder at the Kennecott mine while grudgingly nodding to their dividend policy as the one thing keeping the ship afloat—barely. Factual digs into iron ore woes, copper conundrums, and why analysts are yawning with a 'Hold' rating.

In a world obsessed with green energy, BP gets a salty upgrade from analysts betting on higher oil prices and Middle East chaos. We roast the facts: Is this a comeback or just more hot air from a fossil fuel has-been?

In a world where AI is gatecrashing every industry, Expedia Group faces a salty reality check as analysts slash price targets amid disruption fears. Despite solid earnings, the OTA giant's stock is getting roasted – here's the due diligence with a side of sarcasm.

In a market where insurance stocks are getting pummeled like a piñata at a bad party, Progressive (PGR) struts in with earnings that actually don't make you want to hurl. We dive into the salty truth behind their surge, roasting the sector while keeping it real—no bullshit, just facts and a side of sarcasm.

In a market full of overconfident bears, SWK Holdings Corp. (NASDAQ:SWKH) just watched short interest plummet 30.8% in February. We roast the data, salt the skepticism, and dig into why this tiny finance play might be laughing last – all while keeping it real and factual.

A salty take on SolarEdge's recent surge toward its 52-week high, driven by solid earnings and a mysterious AI tech deal. We roast the highs and lows of this solar inverter play while keeping it real with the facts.

In this opinion piece, we roast Warner Bros. Discovery's (WBD) latest drama: Netflix bailing on their asset grab, leaving WBD looking like yesterday's popcorn. Factual salt on what it means for the media mess, with zero diamond hands required.

A salty take on the Invesco Solar ETF (TAN), roasting its strategy, holdings, and performance while sticking to the facts—no BS, just due diligence with a side of sarcasm.

Buckle up for a no-holds-barred, sarcasm-laced opinion on the Strive 500 ETF (STRV), where we dissect its latest price flop at $42.67 and wonder why anyone would touch this S&P wannabe with a ten-foot pole. Factual burns only, no bullshit advice.

In a market full of fireworks, Reynolds Consumer Products (REYN) is the dull thud of aluminum foil unrolling. Clifford Capital Partners just bumped their stake, but is this a vote of confidence or just not selling the farm? A salty dive into the mundane empire of kitchen wraps and bags.

In a move that screams 'desperate diversification,' Chilton Investment Co. snaps up over 100k shares of T. Rowe Price Group. We dive into the salty reality of TROW's mixed earnings, institutional tinkering, and that dividend tease – all while questioning if this old-school fund manager is just treading water in a shark-infested market.

In a market full of head-scratchers, Chilton Investment's massive bet on Martin Marietta Materials screams 'we see something you don't,' even as the company trips over its own quarterly results. A salty dive into the absurdity of piling into aggregates amid earnings whiffs and steady dividends.

In a move that's got investors scratching their heads, Quinn Opportunity Partners LLC slashed its LendingClub holdings by over 30%, selling off 101,400 shares despite the company's solid Q4 beat and sunny guidance. We roast the irony, salt the sell-off, and dig into what this means for LC's meme-worthy rollercoaster.

In a move that's got investors scratching their heads, Ameriprise Financial slashed its Lam Research stake by nearly 17%. We dive into this salty decision with a roast-heavy due diligence, questioning if AMP's crystal ball is foggy or if they're just dodging a chip sector storm.

A no-holds-barred, sarcasm-laced dive into Mustang Bio Inc (MBIO) stock's grim 2026 forecast. We roast the red flags, mock the volatility, and question why anyone would touch this falling knife – all while sticking to the facts from the latest analysis.

A no-holds-barred, salty opinion on the iShares MSCI Saudi Arabia ETF (KSA), where we roast its yawn-inducing stability while factually dissecting BlackRock's desert darling and what it means for your portfolio – all without the hype or hard sell.

A no-holds-barred, sarcastic romp through Fox Corporation's latest SEC filings, roasting the legal headaches, insider shenanigans, and financial fine print that make due diligence feel like a bad hangover.

A salty, no-holds-barred due diligence roast of the iShares LifePath Target Date 2030 ETF (ITDB), dissecting its sleepy stats and questioning if this fund-of-funds snoozefest deserves a spot in your portfolio.

A no-holds-barred, sarcastic dive into Huadi International Group Co., Ltd. (HUDI), roasting its steel pipe empire, opaque finances, and the wild ride of investing in a NASDAQ-listed Chinese firm. Factual due diligence with a heavy dose of humor and skepticism.

In this salty take on Amcor's acquisition of Berry Global, we roast the uncertainties, synergies, and sector headaches that could make or break this deal. Factual due diligence with a side of sarcasm—no advice, just the cold, hard facts.

A salty, no-holds-barred opinion on the Global X S&P Catholic Values Developed Ex-U.S. ETF (CEFA), roasting its choppy performance, divergent sentiments, and the AI trading gimmicks that won't save your ass from downside risk.

In this salty take on Burning Rock Biotech (BNR), we roast the biotech's Q3 2025 results where losses dipped but profitability remains a distant dream. Steady revenue can't mask the ongoing bleed, and with a dirt-cheap valuation amid wild stock swings, investors might be wise to keep their powder dry – or at least their expectations low.

In this salty take on Takeda Pharmaceutical's ADR (TAK), we roast the company's rock-steady stock price amid sector chaos, poke fun at its dividend allure and pipeline promises, while calling out the generic threats and regulatory headaches that could turn this pharma play into a snoozefest.

Hedge fund Simcoe Capital ramps up its stake in Donnelley Financial Solutions (DFIN), betting big on a stock that's been sleepwalking sideways. We dive into the due diligence with a hefty dose of sarcasm—because nothing says 'growth' like a trading range tighter than a cheap suit.

In a move that's about as surprising as a rainy day in Seattle, Blue Hat Interactive Entertainment Technology (BHAT) just got slapped with a Nasdaq delisting notice. We dive into the salty details of this corporate clown show, roasting the facts without the fluff.

A salty take on TFS Financial director Anthony Asher's recent stock purchase, questioning if it's a sign of undervaluation or just insider optimism in a meh market.

In this opinion piece, we roast DoorDash's involvement in Pi Day deals, questioning the real value behind the discounts while digging into the company's delivery empire with sarcasm and facts.

A salty take on American States Water (AWR) as it stumbles from highs despite solid results and big spending plans—dividends keep it afloat, but is this pullback a bargain or just more utility drama?

In this salty due diligence take, we roast AMN Healthcare's latest earnings call transcript, highlighting the mundane financials, vague outlook, and industry headwinds that make this staffing giant feel like yesterday's news. All facts, no fluff, just pure sarcasm.

In a move that's got the biotech world snickering, GSK's Arexvy RSV vaccine just got FDA greenlight for younger adults, cranking up the heat on Moderna's mResvia. We dive into the salty details of this rivalry, roasting the implications for MRNA holders without a shred of mercy or advice.

In a move that's got shareholders scratching their heads, Thomson Reuters is pushing for a $605 million cash bonanza followed by a share mash-up. We dive into this salty saga with due diligence that's equal parts roast and reality check.

In this salty take on Wabtec (WAB), we roast the irony of a major fund slashing its stake amid blowout earnings, raised guidance, and juicy buybacks. Factual due diligence with a side of sarcasm—because nothing says 'bullish' like insiders cashing out.

A salty due diligence dive into Waste Management (WM), roasting its trash empire while eyeing competitor Republic Services' shiny Q4 glow-up. Factual jabs at the business, numbers, and why this landfill lord might be full of crap – or not.

Surf Air Mobility's latest quarterly report is a masterclass in financial faceplants, with a $27.2 million loss nearly swallowing its $29.2 million revenue whole. We roast the numbers, question the endless dilution, and side-eye the electrification dreams that might just keep this bird grounded.

In a move that's got all the subtlety of a sinking ship bailing out water with a teaspoon, Q/C Technologies, Inc. (NASDAQ: QCLS) has dumped its auditor Stephano Slack LLC after back-to-back 'going concern' warnings. We dive into this salty saga with facts, sarcasm, and zero illusions about the company's financial tightrope walk.

In a move that's got Purple Biotech (PPBT) shareholders clutching their pearls, CEO Gil Efron is stepping down due to health issues. We roast the announcement, the stock dip, and the endless CEO carousel in biotech – all while keeping it real and salty.